Literature DB >> 8238231

Muscle loss from doxorubicin injections into the eyelids of a patient with blepharospasm.

L K McLoon, J D Wirtschafter, J D Cameron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8238231     DOI： 10.1016/s0002-9394(14)73213-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  4 in total

1.  Exercise stimulates beneficial adaptations to diminish doxorubicin-induced cellular toxicity.

Authors:  Ashley J Smuder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-08-28       Impact factor: 3.619

Review 2.  Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.

Authors:  Laura A A Gilliam; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2011-06-15       Impact factor: 8.401

3.  Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle.

Authors:  Andrew R Harrison; Zachary Berbos; Renzo A Zaldivar; Brian C Anderson; Mollie Semmer; Michael S Lee; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-23       Impact factor: 4.799

4.  Stem Cell-Derived Exosomes Ameliorate Doxorubicin-Induced Muscle Toxicity through Counteracting Pyroptosis.

Authors:  Fatima Bianca A Dessouki; Rakesh C Kukreja; Dinender K Singla
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.